We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients.
- Authors
Woo, Marcel S.; Steins, David; Häußler, Vivien; Kohsar, Matin; Haag, Friedrich; Elias-Hamp, Birte; Heesen, Christoph; Lütgehetmann, Marc; Schulze zur Wiesch, Julian; Friese, Manuel A.
- Abstract
Dear Sirs, Individuals with autoimmune diseases, such as multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD), that require long-term immunosuppression are regarded as particularly vulnerable in the current COVID-19 pandemic [[1]]. The patient was tested positive for SARS-CoV-2 by PCR on April 29th, 2020 (Ct 36). 7191287 2 Long Q-X, Liu B-Z, Deng H-J. Antibody responses to SARS-CoV-2 in patients with COVID-19.
- Subjects
NEUROMYELITIS optica; COVID-19; INFECTION control; TYPE 2 diabetes
- Publication
Journal of Neurology, 2021, Vol 268, Issue 1, p5
- ISSN
0340-5354
- Publication type
Letter
- DOI
10.1007/s00415-020-10046-8